Samsung Biologics
Tracked across 1 events · 7 articles · First seen Feb 03, 2026 · Last active Feb 03, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Samsung Biologics is joining CEPI's VMFN, enhancing its role in global health preparedness and securing a significant partnership for future vaccine manufacturing. This collaboration leverages Samsung Biologics' large-scale mammalian cell-based infrastructure and advanced regulatory systems, positioning it as a key player in rapid recombinant-protein vaccine production. The agreement also ensures Samsung Biologics will provide guaranteed vaccine doses for CEPI and South Korea.
Feb 03, 2026 · 7 articles
John Rim
President and CEO
↔
Samsung Biologics
John Rim is the President and CEO of Samsung Biologics.
Coalition for Epidemic Preparedness Innovations
member of
↔
Samsung Biologics
Samsung Biologics is a member of CEPI's Vaccine Manufacturing Facility Network.
NEWSDESK
Track Samsung Biologics live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard